For instance, prostate-specific antigen (PSA), commonly used for prostate cancer detection, may present elevated levels due to benign prostatic hyperplasia or prostatitis, leading to false-positive results that can unnecessarily increase patient stress and lead to additional invasive testing. This evidence concerns the gene PROS1 and urogenital neoplasm.